Vitamin D 125
Posted on 06 October 2010
Press Release Merck today announced the final results from two pivotal studies III Phase boceprevir, its investigational oral hepatitis C protease inhibitor, will be presented in plenary oral session 61 Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), which is taking place from October 29th through November 2 in Boston.
Vitamin D is better than ANY vaccine and increases the immune system by 3-5 times
No responses yet. You could be the first!